Shared Decision-making in ITP

CE / CME

Fundamentals III: Improving Shared Decision-making and Addressing Healthcare Disparities

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Released: October 18, 2024

Expiration: April 17, 2025

Tara Azizi
Tara Azizi, MSN, AGPCNP-BC, CRNP
Lucus W. Enslin
Lucus W. Enslin, MSN, FNP-BC
Jennifer Mead
Jennifer Mead, PA-C

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Patient Case: 36-Yr-Old Woman



  • 36-yr-old woman presents to the hematology clinic with a 7-mo history of ITP

  • She was initially treated with corticosteroids, which temporarily raised her platelet count, but the count dropped again upon tapering

  • She is hesitant to start second-line treatment due to concerns about adverse effects, and she frequently misses follow-up appointments because of transportation issues and long clinic wait times

  • The patient also expresses frustration with her condition, noting that she feels overwhelmed by the treatment options and is anxious about the potential long-term adverse effects of immunosuppressive therapies

  • In addition, she has difficulty affording her medications and is unsure of how to navigate her insurance benefits

Which of the following is the most appropriate strategy to address the patient’s transportation concerns regarding clinic visits?